These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39267061)

  • 1. Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy.
    Zeng B; Pian L; Liu Y; Wang S; Wang N; Liu C; Wu H; Wan H; Chen L; Huang W; Gao Z; Yin X; Jin M
    J Nanobiotechnology; 2024 Sep; 22(1):558. PubMed ID: 39267061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor.
    Huang C; Yang X; Li H; Zhang L; Guo Q; Yu Q; Wang H; Zhang L; Zhu D
    J Nanobiotechnology; 2024 Sep; 22(1):542. PubMed ID: 39238020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
    Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
    Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
    [No Abstract]   [Full Text] [Related]  

  • 7. Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy.
    Yu N; Zhou J; Xu H; Wang F; Wang X; Tang L; Li J; Wang X; Lu X
    Biomater Adv; 2024 Oct; 163():213962. PubMed ID: 39032435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer.
    Zhang R; Zhu Z; Lv H; Li F; Sun S; Li J; Lee CS
    Small; 2019 Dec; 15(49):e1903881. PubMed ID: 31702880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
    Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
    Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
    Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
    Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
    Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified Docetaxel/IR820 Co-loaded micelles.
    Li W; Peng J; Tan L; Wu J; Shi K; Qu Y; Wei X; Qian Z
    Biomaterials; 2016 Nov; 106():119-33. PubMed ID: 27561883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.
    Broekgaarden M; Weijer R; van Wijk AC; Cox RC; Egmond MR; Hoebe R; van Gulik TM; Heger M
    J Biomed Nanotechnol; 2017 Feb; 13(2):204-20. PubMed ID: 29377650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
    Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
    J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
    Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
    Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.
    Xiong W; Qi L; Jiang N; Zhao Q; Chen L; Jiang X; Li Y; Zhou Z; Shen J
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8026-8041. PubMed ID: 33577301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of Upconverted Metal-Organic Frameworks for Near-Infrared Light-Triggered Combinational Photodynamic/Chemo-/Immunotherapy against Hypoxic Tumors.
    Shao Y; Liu B; Di Z; Zhang G; Sun LD; Li L; Yan CH
    J Am Chem Soc; 2020 Feb; 142(8):3939-3946. PubMed ID: 31968933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.